Function: Professional PhD
My motivation to research is that better understanding of pharmaceutical policy leads better decision making for us. Also, I believe comparative studies across health systems will help us to learn from each other country, to develop the system better.
Education and experience:
Junhee Pyo obtained her Bachelor and Master of Pharmacy at Seoul National University, College of Pharmacy in Korea. Also, she got Master of Science in pharmacoepidemiology at Harvard School of Public Health in 2012. After completion of training, she worked as a research associate at Center for Evaluation of Value and Risk in Health, Institute of Clinical Research and Health Policy, Tufts Medical Center in Boston, USA for two years. She started her professional PhD studies at the WHO Collaborating Center for Pharmaceutical Policy and Regulation, Department of Pharmaceutical Science, Utrecht University in 2014. At present, she starts to work the health economic and outcome research & pricing projects as a Sr. research associate at the IMS Health in Seoul. Her research interests include pharmaceutical policy evaluation in medicines, economic evaluation, and health technology assessment decision and uptake variations across countries.
Title PhD project:
Orphan medicine access and policy evaluation across countries.
PhD project description:
This research starts from concerns on inequity in orphan medicine products access and uptake due to policy across countries. The research project aims to investigate a global variability in orphan medicine product access and relevant policy evaluation, covering European countries, Asia pacific regions and the United States. The impact of public payer’s policy to orphan medicine products was not thoroughly evaluated yet. Finally, this study will provide timely review of current global situation regarding variations of access to orphan medicine products and varieties of policy implementations in a horizontal perspective. It will help implement evidence-based policies about OMPs based on scientific evaluations.
Teammembers and other people involved: